Cutaneous tissue engineering and lower extremity wounds (part 2)

International Journal of Lower Extremity Wounds

Volumn 5, Issue 1, 2006, Pages 27-34

  Dini, Valentina ^a   Romanelli, Marco ^a   Piaggesi, Alberto ^a   Stefani, Alessandro ^a   Mosca, Franco ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Bioengineered skin equivalents; Chronic venous ulcers; Diabetic foot ulcers; Skin diseases; Wound healing

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; CHONDROITIN 6 SULFATE; COLLAGEN; CORTICOSTEROID; CYCLOSPORIN; CYTOKINE; EPIDERMAL GROWTH FACTOR; IMMUNOSUPPRESSIVE AGENT; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA;

ALLOGRAFT; ANGIOGENESIS; AUTOGRAFT; BIOENGINEERING; CLINICAL TRIAL; COMPRESSION THERAPY; CRYOPRESERVATION; DECUBITUS; DIABETIC FOOT; FIBROBLAST; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KERATINOCYTE; LEG ULCER; PRIORITY JOURNAL; PYODERMA GANGRENOSUM; REVIEW; SKIN DISEASE; TISSUE ENGINEERING; ULCER; UNSPECIFIED SIDE EFFECT; WOUND; WOUND CLOSURE; WOUND DRESSING; WOUND HEALING; XENOGRAFT;

HUMANS; LEG ULCER; PRESSURE ULCER; SKIN; SKIN DISEASES; TISSUE ENGINEERING; WOUND HEALING;

EID: 32944468062     PISSN: 15347346     EISSN: None     Source Type: Journal    
DOI: 10.1177/1534734606286464     Document Type: Review

References (39)

1. Falanga V. Classifications for wound bed preparation and stimulation of chronic wounds. Wound Repair Regen 2000 ; 8: 347-352.
2. Boschi E, Longoni BM, Romanelli M, Mosca F. Cutaneous tissue engineering and lower extremity wounds (Part 1). Int J Lower Extremity Wounds 2004 ; 3 (2). 80-86.
3. Jimenez PA, Jimenez SE. Tissue and cellular approaches to wound repair. Am J Surg 2004 ; 187 (Suppl. May). 56S - 64S.
4. Jahoda CA, Reynolds AJ. Hair follicle dermal sheath cells: unsung participants in wound healing. Lancet 2001 ; 358: 1445-1448.
5. Eaglstein WH, Alvarez OM, Auletta M, et al. A composite skin substitute (Graftskin®) for surgical wounds: a clinical experience. Dermatol Surg 1995 ; 21: 839-843.
6. Mansbridge J, Liu K, Patch R, Symons K, Pinney E. Three-dimensional fibroblast culture implant for the treatment of diabetic foot ulcers: metabolic activity and therapeutic range. Tissue Eng 1998 ; 4: 403-414.
7. Phillips TJ, Dover JS. Leg ulcers. J Am Acad Dermatol 1991 ; 25: 965-987.
8. Bell E, Ehrlich HP, Buttle DJ, Nakatsuji T. Living tissue formed in vitro and accepted as skin-equivalent tissue of full thickness. Science 1981 ; 211: 1052-1054.
9. Leigh IM, Purkis PE, Navsaria HA, Phillips TJ. Treatment of chronic venous ulcers with sheets of cultured allogenic keratinocytes. Br J Dermatol 1987 ; 117: 591-597.
10. Sabolinski ML, Alvarez O, Auletta M, Mulder G, Parenteau NL. Cultured skin as a 'smart material' for healing wounds: experience in venous ulcers. Biomaterials 1996 ; 17: 311-320.
11. Falanga V, Margolis D, Alvarez O, et al. Rapid healing of venous ulcers and lack of clinical rejection with an allogenic cultured human skin equivalent. Arch Dermatol 1998 ; 134: 293-300.
12. Falanga V, Sabolinski M. A bilayered living skin construct (APLIGRAF®) accelerates complete closure of hard-to-heal venous ulcers. Wound Repair Regen 1999 ; 7: 201-207.
13. Milstone LM, Asgari MM, Schwartz PM. Growth factor expression, healing and structural characteristics of Graftskin (Apligraf®). Wounds 2000 ; 12 (Suppl A). 12A - 19A.
14. Omar AA, Mavor AID, Jones AM, Homer-Vanniasinkam S. Treatment of venous leg ulcers with Dermagraft®. Eur J Endovasc Surg 2004 ; 27: 666-672.
15. Tausche AK, Skaria M, Bohlen L, et al. An autologous epidermal equivalent tissue-engineered from follicular outer sheath keratinocytes is as effective as split-thickness skin autograft in recalcitrant vascular leg ulcers. Wound Repair Regen 2003 ; 11: 248-252.
16. Mostow EN, Haraway GD, Dalsing M, et al. Effectiveness of an extracellular matrix graft (OASIS Wound Matrix) in the treatment of chronic leg ulcers: a randomized clinical trial. J Vasc Surg 2005 ; 41: 837-843.
17. Lazarus GS, Cooper DM, Knighton DR, et al. Definitions and guidelines for assessment of wounds and evaluation of healing. Arch Dermatol 1994 ; 130 (4). 489-493.
18. Brem H, Balledux J, Bloom T, Kerstein MD, Hollier L. Healing of diabetic foot ulcers and pressure ulcers with human skin equivalent: a new paradigm in wound healing. Arch Surg 2000 ; 135: 627-634.
19. Harding KG, Morris HL, Patel GK. Science, medicine and the future: healing chronic wounds. BMJ 2002 ; 324: 160-163.
20. Apelqvist J, Larsson J. What is the most effective way to reduce the incidence of amputation in the diabetic foot? Diabetes Metab Res Rev 2000 ; 16 (Suppl 1). S75 - S83.
21. Boulton AJM. Clinical presentation and management of diabetic neuropathy and foot ulceration. Diabet Med 1991 ; 8: 552-557.
22. Reiber GE, Vileikyte L, Boyko EJ, et al. Causal pathways for incident lower-extremity ulcers in patients with diabetes from two settings. Diabetes Care 1999 ; 22: 157-162.
23. Gentzkow GD, Iwasaki SD, Hershon KS, et al. Use of Dermagraft, a cultural human dermis, to treat diabetic foot ulcers. Diabetes Care 1996 ; 19: 350-354.
24. Veves A, Falanga V, Armstrong DG, Sabolinski ML. Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers. A prospective randomized multicenter clinical trial. Diabetes Care 2001 ; 24: 290-295.
25. Caravaggi C, Faglia E, De Giglio R, et al. Effectiveness and safety of a non-removable fiberglass off-bearing cast versus a therapeutic shoe in the treatment of neuropathic foot ulcers. Diabetes Care 2000 ; 23: 1746-1751.
26. Armstrong DG, Ngyugen HC, Lavery LA, et al. Off-loading the diabetic foot wound: a randomized clinical trial. Diabetes Care 2001 ; 24: 1019-1022.
27. Piaggesi A, Viacava P, Rizzo L, et al. Semiquantitative analysis of the histopathological features of the neuropathic foot ulcer: effect of pressure relief. Diabetes Care 2003 ; 26: 3123-3128.
28. Caravaggi C, De Giglio R, Pritelli C, et al. HYAFF 11-based autologous dermal and epidermal grafts in the treatment of noninfected diabetic plantar and dorsal foot ulcers. A prospective, multicenter, controlled, randomised clinical trial. Diabetes Care 2003 ; 26: 2853-2859.
29. Piaggesi A, Baccetti F, Rizzo L, Romanelli M, Navalesi R, Benzi L. Sodium carboxyl-methyl-cellulose dressings in the management of deep ulcerations of diabetic foot. Diabet Med 2001 ; 18 (4). 320-324.
30. Caputo GM, Cavanagh PR, Ulbrecht JS, Gibbons GW, Karchmer AW. Assessment and management of foot disease in patients with diabetes. N Engl J Med 1994 ; 331: 854-860.
31. Uccioli L. Clinical results related to the use of tissuetech autograft system in the treatment of diabetic foot ulceration. Wounds 2003 ; 15: 279-288.
32. Phillips TJ, Bigby M, Bercovitch L. Cultured allografts as an adjunct to the medical treatment of problematic leg ulcers. Arch Dermatol 1991 ; 127: 799-801.
33. De Imus G, Golomb C, Wilkel C, Tsoukas M, Nowak M, Falanga V. Accelerated healing of pyoderma gangrenosum treated with bioengineered skin and concomitant immunosuppression. J Am Acad Dermatol 2001 ; 144: 61-66.
34. Pennoyer JW, Susser WS, Chapman MS. Ulcers associated with polyarteritis nodosa treated with bioengineered human skin equivalent (Apligraf®). J Am Acad Dermatol 2002 ; 46: 145.
35. Drosou A, Kirsner RS, Kato T, et al. Use of a bioengineered skin equivalent for the management of difficult skin defects after pediatric multivisceral transplantation. J Am Acad Dermatol 2005 ; 52: 854-858.
36. Charles CA, Kato T, Tzakis AG, Miller BN, Kirsner RS. Use of a living dermal equivalent for a refractory abdominal defect after pediatric multivisceral transplantation. Dermatol Surg 2004 ; 30 (9). 1236-1240.
37. Falabella AF, Schachner LA, Valencia IC, Eaglstein WH. The use of tissue-engineered skin (Apligraf) to treat a newborn with Epidermolysis bullosa. Arch Dermatol 1999 ; 135: 1219-1222.
38. Wollina U, Konrad H, Fischer T. Recessive epidermolysis bullosa dystrophicans (Hallopeau-Siemens): improvement of wound healing by autologous epidermal grafts on an esterified hyaluronic acid membrane. J Dermatol 2001 ; 28 (4). 217-220.
39. Flores F, Eaglstein WH, Kirsner RS. Hydroxyurea-induced leg ulcers treated with Apligraf. Ann Intern Med 2000 ; 132: 417.